PRINCETON, NJ--GE Healthcare announced today that the Peripheral and Central Nervous System Drugs advisory committee of the U.S. Food and Drug Administration (FDA) has voted to recommend DaTSCAN (Ioflupane I 123 Injection) to the FDA. The panel determined DaTSCAN has a favorable risk to benefit profile, voting 11 to two with one abstention.
business unit
tags
Ranking determined by medical equipment performance data collected from healthcare provider organization
WAUKESHA, WI - The Senographe® DS digital mammography system has been ranked as the #1 digital mammography system in the 2009 Top 20 Best in KLAS® Awards for Medical Equipment in the Digital Mammography category. The announcement was made by GE Healthcare, a division of General Electric Corp. (NYSE: GE).
business unit
tags
With newly dedicated business segment, GE Healthcare announces vision for Molecular Imaging industry; highlights comprehensive solution portfolio.
WAUKESHA, Wis.--12 June 2009-- GE Healthcare will present a new vision for molecular imaging, "Understanding disease. From the beginning," reinforced by its innovative platform of imaging agents and imaging systems at the 56th annual meeting of the Society of Nuclear Medicine, June 13- 17, in Toronto, Canada.
business unit
tags
Expanded Medicare coverage of PET scans improves access for patients to needed cancer diagnosis tool
WAUKESHA, WIS. -- APRIL 07, 2009 -- GE Healthcare, a global leader in healthcare technology, supports the recent national coverage determination (NCD) from the Centers for Medicare and Medicaid Services (CMS), expanding coverage for initial testing with positron emission tomography (PET) for Medicare beneficiaries who are diagnosed with and treated for most solid tumor cancers.
business unit
tags
ORLANDO, FL--GE Healthcare, a unit of General Electric Company (NYSE: GE), presented results from the ADMIRE-HF study at the American College of Cardiology's 58th Annual Scientific Session in Orlando, Florida today. The study involved a nuclear imaging test utilizing the imaging agent AdreView™ (Iobenguane I 123 injection) in heart failure patients who are at a higher risk for cardiac death, disease progression, or cardiac arrhythmias.
ADMIRE-HF Data
business unit
tags
Company Announces New Products, Collaborations and Initiatives at Orlando Expo
ACC.09 Annual Scientific Session Exposition
ORLANDO, Fla.--(BUSINESS WIRE)--GE Healthcare is dedicated to delivering tomorrow's healthcare solutions today. New products, collaborations and ideas are at the heart of the company's product lineup at the American College of Cardiology (ACC) conference, in Orlando through Tuesday, March 31.
business unit
tags
Princeton, NJ--- John Dineen, president and CEO of GE Healthcare, has appointed Pascale Witz to the position of president and CEO, GE Healthcare, Medical Diagnostics. In her most recent assignment, Ms. Witz led GE Healthcare's Healthcare Systems Interventional global business, which researches and develops innovative medical technologies to help physicians diagnose and treat disease earlier, faster and more accurately.